Evidence map›Paper›PMID 28280325›Full record

ArticleInternational journal of nanomedicine2017

Novel route synthesis of porous and solid gold nanoparticles for investigating their comparative performance as contrast agent in computed tomography scan and effect on liver and kidney function.

Farooq Aziz, Ayesha Ihsan, Aalia Nazir, Ishaq Ahmad, Sadia Zafar Bajwa, Asma Rehman, Abdoulaye Diallo, Waheed S Khan

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Porous Gold: A New Frontier for Enzyme-Based Electrodes.Nanomaterials (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Farooq AzizNanobiotechnology Group, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad; Department of Physics, Islamia University of Bahawalpur, Bahawalpur.
Ayesha IhsanNanobiotechnology Group, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad.
Aalia NazirDepartment of Physics, Islamia University of Bahawalpur, Bahawalpur.
Ishaq AhmadNational Center for Physics, Quaid-I-Azam University, Islamabad, Pakistan.
Sadia Zafar BajwaNanobiotechnology Group, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad.
Asma RehmanNanobiotechnology Group, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad.
Abdoulaye DialloLaboratory of Photonics and Nano-Fabrication, Faculty of Science and Technology, Cheikh Anta Diop University of Dakar (UCAD), Dakar-Fann Dakar, Senegal.
Waheed S KhanNanobiotechnology Group, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad.
National Institute for Biotechnology and Genetic Engineering · PKIslamia University of Bahawalpur · PKCheikh Anta Diop University · SNQuaid-i-Azam University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gold nanoparticles (GNPs) with dimension in the range of 1-100 nm have a prominent role in a number of biomedical applications like imaging, drug delivery, and cancer therapy owing to their unique optical features and biocompatibility. In this work, we report a novel technique for the synthesis of two types of GNPs namely porous gold nanoparticles (PGNPs) and solid gold nanoparticles (SGNPs). PGNPs of size 35 nm were fabricated by reduction of gold (III) solution with lecithin followed by addition of L-ascorbic acid and tri-sodium citrate, whereas SGNPs with a dimension of 28 nm were prepared by reflux method using lecithin as a single reducing agent. Comparative studies using PGNPs (λ

Indexed as

AnimalsContrast MediaGoldInjections, IntravenousKidneyKidney Function TestsLiverLiver Function TestsMaleMetal NanoparticlesRabbitsTomography, X-Ray ComputedContrast MediaGoldcontrast agentCT scanliver function testporous gold nanoparticlesrenal function testsolid gold nanoparticles

Identifiers

PMID28280325
PMCPMC5339011
OpenAlexW2594644192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.